Medical Developments International Limited · ASX:MVP
Medical Developments International — FY2005 Earnings Presentation
9 slides from Medical Developments International's earnings presentation, Sep 7, 2005
Slide 1: FY 2005 Results & Outlook
FY 2005 Results & Outlook September 2005
Slide 2: Financial Highlights — FY2005
oS = 2 = © c Sms o Z = fy a iss G = S. 2 © es ® oO @ a ¢e) © = Financial Highlights — FY2005 cy aia aoe - ae nia Lo e as oo a aia sian af | L _ i. a - oe oe. coe - L He _ Lo _ oo ae -_ | oo - . — . | oe 7 | i oS a Ce _ a __ Lo a a 7 * Includes $237k of deferred registration expenditure ic
Slide 3: Financial Highlights — FY2005
oS = 2 = © c Sms o Z = fy a iss G = S. 2 © es ® oO @ a ¢e) © = Financial Highlights — FY2005 . . Sales Gross Profit Business Unit $'000 $000 Comment
Slide 4: Expect significant growth from new markets
Outlook: Penthrox Expect significant growth from new markets Dentistry « Product launched in June 2005 and distributed by Henry Schein, one of the world’s leading distributors of dental products « The launch has been backed with: * anational lecture circuit «advertising in industry publications; and
Slide 5: Expect significant growth from new markets
Outlook: Penthrox Expect significant growth from new markets Dentistry Penthrox has had an excellent response from patients and dentists “Penthrox arrived Monday lunch in post. At 4pm had a 13 year old female for 14 24 ortho exos. She was crying and very anxious having spent all holidays getting psy
Slide 6: Expect significant growth from new markets
Outlook: Penthrox Expect significant growth from new markets Hospitals « The hospital strategy is still under development and significant sales are not expected until the second half of FY06 « New trial data is being generated * Children: with upper limb fractures (Westmead Hospital) * transported t
Slide 7: Overseas registrations and sales are imminent.
Outlook: Penthrox Overseas registrations and sales are imminent. USA research laboratory sales should start shortly Overseas Registrations * GCC countries (Saudi Arabia, Qatar, UAE, Bahrain, Kuwait & Oman) « MDi’s manufacturing plant inspected April 2005 and manufacturing licence issued May 2005 « A
Slide 8: Medical Devices & Veterinary
Outlook: Medical Devices & Veterinary Medical devices and Veterinary products expected to grow Medical Devices * MDI sells medical devices (asthma and oxygen related) in Australia, New Zealand, Canada, Europe and Asia "The company has seen improved sales in the first two months of FY06 « Additional
Slide 9: Outlook Summary
Outlook Summary Forecasting substantial increase in sales and profits in FY2006 = Growth will be mainly revenue driven * Dentistry and hospital sales in Australia/New Zealand * Middle East military and ambulance sales " Improved medical device sales internationally * Launch of new product " Moderate
Medical Developments International — FY2005 Earnings Presentation on 6ix